Want to see DH full AI Analyst Report?
DH Stock Chart & Stats
$1.03
-$0.06(-1.41%)
At close: 4:00 PM EST
$1.03
-$0.06(-1.41%)
Day’s Range― - ―
52-Week Range$0.62 - $4.70
Previous CloseN/A
Volume69.97K
Average Volume (3M)338.90K
Market Cap
$112.08M
Enterprise Value$95.56M
Total Cash (Recent Filing)$178.09M
Total Debt (Recent Filing)$169.84M
Price to Earnings (P/E)―
Beta1.66
Next Earnings
Aug 12, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.62
Shares Outstanding105,524,240
10 Day Avg. Volume311,870
30 Day Avg. Volume338,897
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.26
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue0.40
Enterprise Value/Gross Profit0.55
Enterprise Value/Ebitda8.24
Forecast
1Y Price Target
$1.45Price Target Upside40.78% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering6
EPS Forecast (FY)0.18
Revenue Forecast (FY)$223.30M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsConsistently strong gross margins (~76–81%) indicate durable unit economics for Definitive Healthcare. High gross margins provide structural cushion to fund product development and sales while absorbing top-line softness, supporting long-term margin expansion if operating costs are controlled.
Positive Free Cash Flow GenerationThe company generates positive operating and free cash flow despite GAAP losses, providing financial flexibility to invest in integrations, AI, and services. Durable FCF gives ability to fund strategic initiatives, reduce reliance on external capital, and support a sustainable path to profitability.
Faster Integrations And AI/product RoadmapSignificant improvements in integration speed and a clear AI roadmap reduce customer onboarding friction and improve time-to-value. Faster integrations plus planned AI features bolster retention, enable upsells, and support scalable monetization across life sciences and provider customers over the medium term.
Bears Say
Revenue ContractionSustained top-line declines reduce operating leverage and make profitability gains more fragile. Continued revenue contraction, especially in a core segment, forces greater reliance on cost cuts and non-recurring actions to reach targets and increases execution risk over the next several quarters.
Persistent GAAP LossesOngoing operating and net losses have driven negative returns on equity and pressure on the balance sheet. Until revenue stabilizes, sustained GAAP profitability is uncertain, limiting reinvestment capacity and making long-term value creation contingent on durable margin improvement.
Declining Deferred Revenue And Shorter ContractsA shift toward single-year deals and falling deferred revenue/RPO materially reduces revenue visibility and multi-year renewal insulation. Shorter contracts raise churn and upsell risk, weakening the predictability of subscription cash flows and complicating efforts to sustainably grow ARR.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $0.62 and its highest was $4.70 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $112.08M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Aug 12, 2026 which is in 38 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on May 07, 2026. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.033 by $0.027.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.04.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 105,524,240 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.06 in its last earnings report, beating expectations of $0.033. Following the earnings report the stock price went up 3.254%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Definitive Healthcare Corp Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$1.45 (40.78% Upside)
$1.45 (40.78% Upside)
Hedge Fund Trend
Decreased
By 85.7K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.79%
12-Months-Change
Fundamentals
Return on Equity
-67.07%
Trailing 12-Months
Asset Growth
-36.35%
Trailing 12-Months
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
DH Company Deck
DH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive picture: near-term top-line pressures persist, driven by the life sciences segment and a shift to shorter-duration deals (reflected in declines in revenue, deferred revenue, and RPO). Offsetting these headwinds are stronger-than-expected profitability and margin expansion, solid cash generation (~$50M trailing FCF), meaningful operational progress on data quality (claims remediation), faster and more numerous integrations, professional services acceleration (+25% YoY), and a clear AI/innovation roadmap that management expects will drive improved retention and future monetization. The company beat guidance on profit metrics and is maintaining full-year targets while investing in strategic initiatives to return to growth, but material execution is still required to translate operational improvements into sustained top-line growth.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$1.45
▲(40.78% Upside)
Technical Analysis
Ownership Overview
12.25% Insiders
3.86% Mutual Funds
61.17% Other Institutional Investors
18.29% Public Companies and
Individual Investors